Atrial Fibrillation: Technologies and Global Markets Research Report 2017-2023

DUBLIN, Oct. 31, 2018 /PRNewswire/ --

The "Atrial Fibrillation: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The report on Atrial Fibrillation: Technologies and Global Markets covers interventional procedural products, namely Cardiac Ablation products and Left Atrial Appendage closure devices.

The report covers the market dynamics and trends that are shaping the atrial fibrillation treatment interventions. Other subjects discussed in the report are key qualitative factors like epidemiology, categories of atrial fibrillation, key device development and regulations.

The market landscape of atrial fibrillation was studied at a regional level covering North America, Europe, Asia-Pacific and Other markets. Profiles of key leading companies engaged in the marketing and development of atrial fibrillation devices are covered, with additional information on the market position of major companies in the atrial fibrillation market.

Devices included as a part of market estimates are:

    --  Catheter ablation products, including electrophysiology ablation
        catheters, electrophysiology diagnostic catheters, lab systems (3D
        electro-anatomical mapping systems, robotic catheter navigation systems,
        intracardiac echocardiography systems, recording systems, ablation
        generators and irrigation pumps), access devices and consumables.
    --  Left atrial appendage closure devices, including all occlusion device
        systems and implantable devices employed in endocardial and epicardial
        LAA procedures, which include cardiac plugs, clips and suture delivery
        systems.

The Report Includes:

    --  25 data tables and 13 additional tables
    --  An overview of the global market for atrial fibrillation and
        technologies
    --  Analyses of global market trends, with data from 2017, estimates for
        2018, and projections of compound annual growth rates (CAGRs) through
        2023
    --  Detailed description of the market for drug treatment, surgical
        intervention, and other aspects of atrial fibrillation
    --  Discussion of the types of atrial fibrillation treatment
    --  A look into various government regulations
    --  Insight into the emerging developmental technologies and clinical trials
        for new technology for atrial fibrillation
    --  Company profiles of the manufacturers of surgical equipment, surgical
        accessories, and pharmaceuticals, including Abbott Laboratories, Aegis
        Medical Innovations, Boston Scientific, GE Healthcare, Johnson &
        Johnson, Medtronic and Philips Healthcare

Key Topics Covered:

Chapter 1 Introduction

    --  Study Goals and Objectives
    --  Reasons for Doing this Study
    --  Scope of Report
    --  Methodology
    --  Geographic Breakdown
    --  Analyst's Credentials
    --  Custom Research
    --  Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Background

    --  Heart Structure and Function
    --  Cardiac Arrhythmia
    --  Treadmill Run Test Stress Test
    --  Holter Monitoring
    --  Echocardiography
    --  Electrophysiologic Testing
    --  Atrial Fibrillation (AFib)
    --  Symptoms
    --  Global Epidemiology
    --  Economic Burden of Atrial Fibrillation
    --  Risk Factors
    --  Complications of Atrial Fibrillation
    --  Patterns of Atrial Fibrillation
    --  Current Standard of Care for Atrial Fibrillation
    --  Diagnosis
    --  Treatment of AFib

Chapter 4 Market Overview

    --  Market Dynamics
    --  Market Drivers
    --  Market Restraints
    --  Emerging Trends
    --  Regulatory Landscape
    --  Regulation in Europe
    --  Regulation in the U.S.
    --  Regulation in Japan
    --  Regulation in China
    --  Regulation in India

Chapter 5 Market Breakdown by Device Type

    --  Introduction and Global Markets
    --  Catheter Ablation Devices
    --  Overview
    --  Market Size and Forecast
    --  Catheter Ablation Devices by Type
    --  Left Atrial Appendage (LAA) Closure Devices
    --  Overview
    --  Cost Benefits of Left Atrial Appendage Closure Devices vs.
        Pharmacological Therapy
    --  Market Size and Forecast
    --  Types of Left Atrial Appendage Implantation

Chapter 6 Market Breakdown by Region

    --  Introduction
    --  North America
    --  U.S.
    --  Canada
    --  Europe
    --  Germany
    --  France
    --  Asia-Pacific
    --  China
    --  Japan
    --  India
    --  Rest of the World

Chapter 7 Competitive Landscape and Recent Developments

    --  Market Share Analysis
    --  Atrial Fibrillation: Company Market Share Analysis
    --  Strategies Adopted by Market Leaders
    --  Catheter Ablation Devices: Company Market Share Analysis
    --  Left Atrial Appendage Closure Devices: Company Market Share Analysis
    --  Barriers to the Entry for New Players
    --  High Degree of Competitiveness
    --  Product Portfolio Analysis
    --  Catheter Ablation Devices Product Portfolio Analysis
    --  Left Atrial Appendage Closure Devices Product Portfolio Analysis
    --  Key Recent Industry Events

Chapter 8 Company Profiles

    --  Abbott Laboratories
    --  Ablacor Medical Corp.
    --  Acutus Medical Inc
    --  Aegis Medical Innovations
    --  Afreeze Gmbh
    --  Atricure Inc
    --  Auris Health (Hansen Medical)
    --  Biotronik
    --  Boston Scientific
    --  Cardiofocus
    --  Cathrx
    --  Ge Healthcare
    --  Johnson & Johnson
    --  Kardium
    --  Lifetech Scientific Corp.
    --  Luxcath
    --  Medtronic
    --  Microport Scientific Corp.
    --  Philips Healthcare
    --  Sentreheart
    --  Stereotaxis

For more information about this report visit https://www.researchandmarkets.com/research/xh3kl6/atrial?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/atrial-fibrillation-technologies-and-global-markets-research-report-2017-2023-300741212.html

SOURCE Research and Markets